Contribution of microRNA to pathological fibrosis in cardiorenal syndrome: Impact of uremic toxins

Physiological Reports

Volumn 3, Issue 4, 2015, Pages

  Rana, Indrajeetsinh ^a   Kompa, Andrew R ^b,c   Skommer, Joanna ^a   Wang, Bing H ^b   Lekawanvijit, Suree ^b   Kelly, Darren J ^c   Krum, Henry ^b   Charchar, Fadi J ^a  

^a UNIVERSITY OF BALLARAT   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AST 120; Indoxyl sulfate; microRNA 21; microRNA 29b; Myocardial infarction; Uremic toxin

Indexed keywords

ANGIOTENSIN RECEPTOR; AST 120; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRONECTIN; INDICAN; KIDNEY INJURY MOLECULE 1; MICRORNA; MICRORNA 21; MICRORNA 29B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMAD7 PROTEIN; SPROUTY PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ARTICLE; CARDIORENAL SYNDROME; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; UREMIA; WESTERN BLOTTING;

EID: 85003451613     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12371     Document Type: Article

References (67)

1. Adam, O., B. Lohfelm, T. Thum, S. K. Gupta, S. L. Puhl, H. J. Schafers, et al. 2012. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res. Cardiol. 107:278.
2. Anavekar, N. S., J. J. McMurray, E. J. Velazquez, S. D. Solomon, L. Kober, J. L. Rouleau, et al. 2004. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 351:1285–1295.
3. Aoyama, I., and T. Niwa. 2001. An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. Am. J. Kidney Dis. 37:S7–S12.
4. Bujak, M., and N. G. Frangogiannis. 2007. The role of TGF- beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 74:184–195.
5. Cushing, L., P. P. Kuang, J. Qian, F. Shao, J. Wu, F. Little, et al. 2011. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45:287–294.
6. van Dijk, A., H. W. Niessen, W. Ursem, J. W. Twisk, F. C. Visser, and F. J. van Milligen. 2008. Accumulation of fibronectin in the heart after myocardial infarction: a putative stimulator of adhesion and proliferation of adipose- derived stem cells. Cell Tissue Res. 332:289–298.
7. Dobaczewski, M., W. Chen, and N. G. Frangogiannis. 2011. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 51:600–606.
8. Dong, S., Y. Cheng, J. Yang, J. Li, X. Liu, X. Wang, et al. 2009. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J. Biol. Chem. 284:29514–29525.
9. Dworak, M., M. Stebbing, A. R. Kompa, I. Rana, H. Krum, and E. Badoer. 2012. Sustained activation of microglia in the hypothalamic PVN following myocardial infarction. Auton. Neurosci. 169:70–76.
10. Eghbali, M., R. Tomek, V. P. Sukhatme, C. Woods, and B. Bhambi. 1991. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ. Res. 69:483–490.
11. Goldberg, A., H. Hammerman, S. Petcherski, A. Zdorovyak, S. Yalonetsky, M. Kapeliovich, et al. 2005. Inhospital and 1- year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am. Heart J. 150:330–337.
12. Goldberg, A., E. Kogan, H. Hammerman, W. Markiewicz, and D. Aronson. 2009. The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction. Kidney Int. 76:900–906.
13. Hao, J., H. Ju, S. Zhao, A. Junaid, T. Scammell-La Fleur, and I. M. Dixon. 1999. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J. Mol. Cell. Cardiol. 31:667–678.
14. Hao, J., B. Wang, S. C. Jones, D. S. Jassal, and I. M. Dixon. 2000. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am. J. Physiol. Heart Circ. Physiol. 279:H3020–H3030.
15. Heimer, R., R. I. Bashey, J. Kyle, and S. A. Jimenez. 1995. TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. J. Mol. Cell. Cardiol. 27:2191–2198.
16. Huang, X. R., A. C. Chung, F. Yang, W. Yue, C. Deng, C. P. Lau, et al. 2010. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 55:1165–1171.
17. Kelly, D. J., J. L. Wilkinson-Berka, T. J. Allen, M. E. Cooper, and S. L. Skinner. 1998. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int. 54:343–352.
18. Kompa, A. R., B. H. Wang, G. Xu, Y. Zhang, P. Y. Ho, S. Eisennagel, et al. 2013. Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction. Int. J. Cardiol. 167:210–219.
19. Lekawanvijit, S., A. Adrahtas, D. J. Kelly, A. R. Kompa, B. H. Wang, and H. Krum. 2010. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur. Heart J. 31:1771–1779.
20. Lekawanvijit, S., A. R. Kompa, M. Manabe, B. H. Wang, R. G. Langham, F. Nishijima, et al. 2012a. Chronic kidney disease- induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS One 7:e41281.
21. Lekawanvijit, S., A. R. Kompa, B. H. Wang, D. J. Kelly, and H. Krum. 2012b. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. Circ. Res. 111:1470–1483.
22. Lekawanvijit, S., S. Kumfu, B. H. Wang, M. Manabe, F. Nishijima, D. J. Kelly, et al. 2013. The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction. PLoS One 8:e83687.
23. Li, Q., D. Zhang, Y. Wang, P. Sun, X. Hou, J. Larner, et al. 2013. MiR-21/Smad 7 signaling determines TGF-beta1- induced CAF formation. Sci. Rep. 3:2038.
24. Liang, H., C. Zhang, T. Ban, Y. Liu, L. Mei, X. Piao, et al. 2012. A novel reciprocal loop between microRNA-21 and TGFbetaRIII is involved in cardiac fibrosis. Int. J. Biochem. Cell Biol. 44:2152–2160.
25. Luna, C., G. Li, J. Qiu, D. L. Epstein, and P. Gonzalez. 2011. Cross-talk between miR-29 and transforming growth factor- betas in trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 52:3567–3572.
26. Meng, X. M., X. R. Huang, J. Xiao, A. C. Chung, W. Qin, H. Y. Chen, et al. 2012. Disruption of Smad4 impairs TGF- beta/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int. 81:266–279.
27. Morishita, Y., H. Yoshizawa, M. Watanabe, K. Ishibashi, S. Muto, E. Kusano, et al. 2014. siRNAs targeted to Smad4 prevent renal fibrosis in vivo. Sci. Rep. 4:6424.
28. Nankervis, S. A., J. M. Mitchell, F. J. Charchar, M. A. McGlynn, and P. A. Lewandowski. 2013. Consumption of a low glycaemic index diet in late life extends lifespan of Balb/c mice with differential effects on DNA damage. Longev. Healthspan 2:4.
29. Niwa, T. 2013. Targeting protein-bound uremic toxins in chronic kidney disease. Expert Opin. Ther. Targets 17:1287–1301.
30. Niwa, T., and M. Ise. 1994. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J. Lab. Clin. Med. 124:96–104.
31. Noetel, A., M. Kwiecinski, N. Elfimova, J. Huang, and M. Odenthal. 2012. microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis. Front. Physiol. 3:49
32. Parikh, C. R., S. G. Coca, Y. Wang, F. A. Masoudi, and H. M. Krumholz. 2008. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch. Intern. Med. 168:987–995.
33. Patel, V., and L. Noureddine. 2012. MicroRNAs and fibrosis. Curr. Opin. Nephrol. Hypertens. 21:410–416.
34. Qin, W., A. C. Chung, X. R. Huang, X. M. Meng, D. S. Hui, C. M. Yu, et al. 2011. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol. 22:1462–1474.
35. Rana, I., M. Stebbing, A. Kompa, D. J. Kelly, H. Krum, and E. Badoer. 2010. Microglia activation in the hypothalamic PVN following myocardial infarction. Brain Res. 1326:96–104.
36. Roderburg, C., G. W. Urban, K. Bettermann, M. Vucur, H. Zimmermann, S. Schmidt, et al. 2011. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53:209–218.
37. Rodrigues Diez, R., R. Rodrigues-Diez, C. Lavoz, S. Rayego- Mateos, E. Civantos, J. Rodriguez-Vita, et al. 2010. Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-beta-independent process. PLoS One 5: e14145.
38. Rodriguez-Vita, J., E. Sanchez-Lopez, V. Esteban, M. Ruperez, J. Egido, and M. Ruiz-Ortega. 2005. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 111:2509–2517.
39. van Rooij, E., L. B. Sutherland, J. E. Thatcher, J. M. DiMaio, R. H. Naseem, W. S. Marshall, et al. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 105:13027–13032.
40. Rosenkranz, S. 2004. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 63:423–432.
41. Roy, S., S. Khanna, S. R. Hussain, S. Biswas, A. Azad, C. Rink, et al. 2009. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 82:21–29.
42. Salic, K., and L. J. De Windt. 2012. MicroRNAs as biomarkers for myocardial infarction. Curr. Atheroscler. Rep. 14:193–200.
43. See, F., W. Thomas, K. Way, A. Tzanidis, A. Kompa, D. Lewis, et al. 2004. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J. Am. Coll. Cardiol. 44:1679–1689.
44. Seeland, U., C. Haeuseler, R. Hinrichs, S. Rosenkranz, T. Pfitzner, K. Scharffetter-Kochanek, et al. 2002. Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur. J. Clin. Invest. 32:295–303.
45. Sharma, H. S., H. A. van Heugten, M. A. Goedbloed, P. D. Verdouw, and J. M. Lamers. 1994. Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem. Biophys. Res. Commun. 205:105–112.
46. Simpson, P. 1985. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ. Res. 56:884–894.
47. Sorescu, D. 2006. Smad3 mediates angiotensin II- and TGF- beta1-induced vascular fibrosis: Smad3 thickens the plot. Circ. Res. 98:988–989.
48. Sun, Y., J. Q. Zhang, J. Zhang, and F. J. Ramires. 1998. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J. Mol. Cell. Cardiol. 30:1559–1569.
49. Szafranska, A. E., M. Doleshal, H. S. Edmunds, S. Gordon, J. Luttges, J. B. Munding, et al. 2008. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin. Chem. 54:1716–1724.
50. Taegtmeyer, H., S. Sen, and D. Vela. 2010. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann. N. Y. Acad. Sci. 1188:191–198.
51. Tang, P.-K., and H.-Y. Lan. 2014. MicroRNAs in TGF- b /Smad-mediated tissue fibrosis. Curr. Pathobiol. Rep. 2: 235–243.
52. Thomas, S. A., J. A. Fallavollita, G. Suzuki, M. Borgers, and J. M. Jr Canty. 2002a. Dissociation of regional adaptations to ischemia and global myolysis in an accelerated Swine model of chronic hibernating myocardium. Circ. Res. 91:970–977.
53. Thomas, W. G., Y. Brandenburger, D. J. Autelitano, T. Pham, H. Qian, and R. D. Hannan. 2002b. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90:135–142.
54. Thum, T., C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, et al. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980–984.
55. Villarreal, F. J., A. A. Lee, W. H. Dillmann, and F. J. Giordano. 1996. Adenovirus-mediated overexpression of human transforming growth factor-beta 1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. J. Mol. Cell. Cardiol. 28:735–742.
56. Wang, B., R. Komers, R. Carew, C. E. Winbanks, B. Xu, M. Herman-Edelstein, et al. 2012. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J. Am. Soc. Nephrol. 23:252–265.
57. Wang, J., Y. Gao, M. Ma, M. Li, D. Zou, J. Yang, et al. 2013a. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem. Biophys. 67:537–546.
58. Wang, J., Y. Wang, Y. Wang, Y. Ma, Y. Lan, and X. Yang. 2013b. Transforming growth factor beta-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium. J. Biol. Chem. 288:10418–10426.
59. Wilkinson-Berka, J. L., G. Tan, K. Jaworski, and A. G. Miller. 2009. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circ. Res. 104:124–133.
60. Winbanks, C. E., B. Wang, C. Beyer, P. Koh, L. White, P. Kantharidis, et al. 2011. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J. Biol. Chem. 286:13805–13814.
61. Woodcock, E. A., B. H. Wang, J. F. Arthur, A. Lennard, S. J. Matkovich, X. J. Du, et al. 2002. Inositol polyphosphate 1- phosphatase is a novel antihypertrophic factor. J. Biol. Chem. 277:22734–22742.
62. Xiao, J., X. M. Meng, X. R. Huang, A. C. Chung, Y. L. Feng, D. S. Hui, et al. 2012. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol. Ther. 20:1251–1260.
63. Yang, F., A. C. Chung, X. R. Huang, and H. Y. Lan. 2009. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta- dependent and -independent Smad pathways: the role of Smad3. Hypertension 54:877–884.
64. Youn, T. J., H. S. Kim, and B. H. Oh. 1999. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade. Basic Res. Cardiol. 94:246–253.
65. Zhang, S., T. Fei, L. Zhang, R. Zhang, F. Chen, Y. Ning, et al. 2007. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol. Cell. Biol. 27:4488–4499.
66. Zhang, Y., X. R. Huang, L. H. Wei, A. C. Chung, C. M. Yu, and H. Y. Lan. 2014. miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF- b /Smad3 signaling. Mol. Ther. 22:974–985.
67. Zhong, X., A. C. Chung, H. Y. Chen, X. M. Meng, and H. Y. Lan. 2011. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J. Am. Soc. Nephrol. 22:1668–1681.